Seattle, WA -- (SBWIRE) -- 10/18/2016 -- The global single-use bioprocessing market is projected to reach USD 5.44 Billion by 2021 from USD 2.47 Billion in 2016, at a CAGR of 17.8% from 2016 to 2021.
Factors such as increasing demand for biopharmaceuticals, high energy efficiency, low water usage, less floor space requirement, very low risk of product cross contamination, and faster to implement are the key drivers for the growth of the global single use bioprocessing market. On the other hand, extractability and leachability issues regarding disposable components like plastic bags, and environmental and economic concerns are the major factors that are restraining the growth of the single use bioprocessing market. On the other hand, high potential emerging markets such as China, Japan, and Middle East represents significant growth opportunities for the key players in the single-use bioprocessing market. Further, the concern for disposal of single-use processes and issues related to scalability and transfer may pose challenges to the growth of this market during the forecast period.
Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=231651297
The global single-use bioprocessing market is segmented on the basis of products, applications, end users, and regions. By type of product, the market is categorized into media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others (tubing, connectors, and samplers). The media bags and containers segment is expected to account for the largest share of the single-use bioprocessing products market in 2016. This large share can be attributed to the increasing adoption of media bags and containers in transportation and storage application.
Furthermore, on the basis of application the single-use bioprocessing market is segmented into filtration, storage, cell culture, mixing, and purification. The filtration application segment is expected to account for the largest share of the single-use bioprocessing application market in 2016. This large share can be attributed to the increasing adoption of single-use tangential flow filters, depth filters, and chromatography columns in the process development.
On the basis of region, the single-use bioprocessing market is segmented into North America (U.S. & Canada), Europe, Asia-Pacific (China, Japan, India, and RoAPAC) and Rest of the World. In 2016, North America is expected to account for the largest share of the single-use bioprocessing market, followed by Europe. Both markets are estimated to register double-digit growth rates from 2016 to 2021. However, Asia-Pacific is expected to register a higher growth rate during the forecast period, owing to huge investment opportunities in this region. The growth of the single-use bioprocessing market in the Asia-Pacific region will revolve around China, India, Australia, and New Zealand.
Major players operating in the single-use bioprocessing market are Thermo Fisher Scienctific (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), and Merck Milipore (Germany).